Company / Capital Returned to Shareholders per Share
Caris Life Sciences, Inc. Capital Returned to Shareholders per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$0.00
FY2025
5-year range
$0.00 / $0.00
FY2023-FY2025
Trend
-
vs FY2024
Sector context
#94 of 108
Health Care
What the data says
Caris Life Sciences, Inc.'s capital returned to shareholders per share of $0.00 is lower than 87% of companies in the Health Care sector (FY2025). Improved from $0.00 to $0.00 over the past 2 years.
Based on SEC 10-K filings.
0.00 in FY2025.
Improved from $0.00 to $0.00 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 108This company $0.00 Sector average $5.07
▼
-99.9% below sector average
Key checks
Key Insights
- Ranks #94 out of 108 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | - |
| FY2024 | $0.00 | - |
| FY2023 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026